Testing for Intrinsic Factor Levels
The most clinically useful test is measuring intrinsic factor antibodies (IFA) in serum, not direct intrinsic factor levels, as IFA testing has high specificity (95%) for autoimmune gastritis and is readily available in clinical practice 1, 2.
Why Not Direct Intrinsic Factor Measurement?
While direct measurement of intrinsic factor is technically possible, it is not available for routine clinical use in most settings:
- Gastric juice IF assays require endoscopy with gastric aspiration and are impractical for routine diagnosis 3, 4
- Serum IF ELISA has been developed but remains a research tool with limited clinical availability 5
- Historical methods using vitamin B12 binding and microbiological assays are outdated and cumbersome 3
The Recommended Clinical Approach
For patients with suspected autoimmune gastritis (AIG), check intrinsic factor antibodies (IFA) and parietal cell antibodies (PCA) in serum 1:
Antibody Testing Strategy:
IFA: High specificity but lower sensitivity (~32%) for corpus atrophic gastritis 2
- When positive, strongly supports AIG diagnosis
- More prevalent in younger females (43.5% vs 6.6% in males under 65 years) 2
PCA: Most sensitive serum biomarker for AIG but less specific 1
- Can be falsely elevated in H. pylori infection and other autoimmune diseases
- Should be interpreted alongside IFA results
Important Clinical Caveats:
- False positives can occur if serum is drawn within 24 hours of parenteral vitamin B12 administration 4
- IFA positivity occurs independently from anemia and vitamin B12 deficiency 2
- The combination of histology-confirmed atrophic gastritis plus positive IFA provides the strongest diagnostic certainty 1
When Histologic Confirmation is Needed
In the United States, atrophic gastritis diagnosis requires histopathologic confirmation using the updated Sydney protocol with 5 topographically-separated gastric biopsies 1. This approach has nearly 100% sensitivity and should be performed when serologic testing suggests AIG.